Conditions: Influenza Infection
Keywords: Prevention
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 110
Healthy volunteers: yes

Brief summary:
The purpose of this study is to evaluate the safety and immunogenicity of a single subcutaneous injection of TAK-850 as compared to intramuscular injection of TAK-850 in healthy Japanese adults

Detailed description:
The drug being tested in this study is called TAK-850. This drug is being tested to evaluate the safety and immunogenicity of a single subcutaneous injection as compared to a single, intramuscular injection.

A total of 110 healthy participants (55 per group) will take part in this study.

Each participant will be randomly (like flipping a coin) assigned to receive one of the following :

* A single injection of TAK-850, subcutaneously , or
* A single injection of TAK-850, intramuscularly.

Participants will make up to 3 visits to the study site. Total duration of this study is 22 days.

Arms:
arm 1: Single subcutaneous injection of TAK-850 arm 2: Single intramuscular injection of TAK-850

Interventions: intervention 1: Subcutaneous injection of TAK-850 intervention 2: Intramuscular injection of TAK-850
Intervention descriptions: intervention 1: TAK-850 0.5 mL, Subcutaneous injection intervention 2: TAK-850 0.5 mL, Intramuscular injection

Protocol document: